In a separate experiment, the hMSCs in 24-well plates were treated with OM containing 0.5 µg/ml GO, 10 µg/ml CaP, 10.5 µg/ml GO-CaP, and concurrent 0.5 µg/ml GO plus 10 µg/ml CaP (GO+CaP), respectively. The particle-containing OM was changed every 3 days. After two weeks, the calcium content in each well was quantified and normalized to the total protein content in parallel plates.
Phosphate Quantification: After 2 and 3 weeks of particle treatment in OM and GM (negative controls) in parallel plates, the cells were lysed using cell lysis reagent (Pierce TM M-PER TM mammalian protein extraction reagent) then centrifuge at 13,000 rpm for 15 min. The pellet was washed 3 times with water, followed by thorough mixing with 200 µl 10% acetic acid. After centrifuging another time, the supernatant was tested for phosphate content using a quantitative phosphate assay kit (Abcam®, Fisher Scientific, Pittsburgh, PA).
Total Protein Assay: Total protein was extracted from parallel plates (with ARS assay) using Pierce TM total protein extraction reagent and quantified using Pierce TM BCA protein assay kit with bovine serum albumin as a standard.
Immunofluorescence imaging: The osteogensis of hMSCs was examined by immunostaining of osteoblast markers osteocalcin (OCN, Santacruz biotechnology, TX) and alkaline phosphatase (ALP, BD Bioscience, San Jose, CA) after two weeks of incubation. 20,000 hMSCs were seeded on 8-well chamber slides (Lab-Tek TM , Fisher Scientific, Pittsburgh, PA) with GM. After 24 h, the medium was changed to control OM or particle-containing OM, and then changed every 3 days. After two weeks, the cells were washed with PBS twice, fixed with 4% paraformaldehyde for 10 minutes at room temperature, permeabilized with 0.1% Triton-X100 for 10 min, and blocked with 1% BSA/10% normal goat serum for 1 h at room temperature. For OCN staining, cells were incubated with primary antibody (1:200) to OCN for 1 h at room temperature, washed three times with PBS, and then incubated with goat anti-mouse FITC labelled IgG (1:200) for 2 h followed by two washes of PBS. For ALP staining, cells were incubated with Alexa 488 labeled primary antibody to ALP (1:500) for 1 h at room temperature and washed three times with PBS. Cover slips were mounted with Prolong® gold antifade mounting medium containing DAPI nuclear stain (Life Technologies, Grand Island, NY) onto the slides. Immunofluorescence images were acquired with a Nikon Eclipse fluorescence microscopy (Nikon, Tokyo, Japan).
Results:
Quantification assays of calcium and phosphate content in mineral deposition have been conducted on hMSCs cultured with GO, CaP, and GO-CaP treatments in OM as well as cells with treatments in GM. Significant calcification is observed with all treatments in OM as shown by ARS images in Figure S3 Figure S1 : Cell viability of hMSCs by MTT assay (ratioed to control) with 72 hours treatments by GO microflakes (A), CaP nanoparticles (B), and GO-CaP nanocomposites (C). The star signs mark the concentrations of particles selected for usage in the current study. 
